Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-02-04 @ 2:55 AM
Study NCT ID:
NCT02987166
Status:
COMPLETED
Last Update Posted:
2020-12-16
First Post:
2016-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HDCRT Plus Pembrolizumab in Advanced Malignancies
Sponsor:
James Larner, MD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor | View |